Upcoming results from a bunch of clinical trials could extend the rally stocks have already been enjoying the past few years.

"It is imperative that healthcare providers educate their patients on how to administer the medication safely," experts told Newsweek.

“The cost of some diabetes medications has risen more than tenfold.” Eli Lilly and Company, Novo Nordisk and Sanofi, which ...

In August, most of the $347 million went to biotechnology companies with some money finding its way toward computing and ...

Indianapolis-based Eli Lilly and Co. is ramping up its campaign against imitations of its blockbuster appetite-suppressing drugs, seeking to put an end to a regulatory designation that has allowed ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 626.12% and ...

Deutsche Bank analyst Emmanuel Papadakis maintained a Hold rating on CureVac (CVAC – Research Report) today and set a price target of ...

In a profound revelation that underscores the critical importance of addressing mental health on a global scale, a recent ...

International drugmaker, Eli Lilly, announced plans in May to invest $5.3 billion (€4.9 billion) in a new manufacturing site ...

Eli Lilly is intensifying its efforts to combat imitation versions of its popular appetite-suppressing drugs, Mounjaro and ...

With the heart failure (HF) patient population rapidly expanding, the timing is right for Bayer’s Kerendia (finerenone). | At ...

Eli Lilly And Co’s Profitability and Valuation Ratios Eli Lilly And Co’s profitability metrics reveal strong financial health. The company currently boasts an operating margin of 34.50% and a profit ...